SVA logo

Sinovac Biotech (SVA) Gross Profit

Annual Gross Profit

$266.75 M
-$541.55 M-67.00%

01 December 2023

3-Year Change

-39.85%
SVA annual gross profit is down -39.85% over the past 3 years

5-Year Change

+30.17%
SVA annual gross profit is up +30.17% over the past 5 years

All-time High

$18.30 B
SVA annual gross profit is currently -98.54% below its historical high of $18.30 billion

Sector Rank

70.01%
SVA annual gross profit is higher than 70.01% of companies in Healthcare sector

Annual Gross Profit Formula

Revenue − Cost Of Goods Sold
Annual Gross Margin59.51%
SVA annual gross profit margin is 59.51%
Annual Revenue$448.27 M
SVA annual revenue is $448.27 million
Annual Net Income-$99.92 M
SVA annual net profit is -$99.92 million

SVA Gross Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Gross Profit

N/A

01 June 2024

All-time High

$283.93 M
SVA quarterly gross profit is currently at an all-time high

SVA Quarterly Gross Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Gross Profit

N/A

01 June 2024

All-time High

$443.44 M
SVA TTM gross profit is currently at an all-time high
Annual Gross Margin59.51%
SVA annual gross profit margin is 59.51%

SVA TTM Gross Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SVA Gross Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years-39.9%--
5 y5 years+30.2%--

SVA Gross Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-98.5%at low
5 y5 years-98.5%+30.2%
alltimeall time-98.5%>+9999.0%

Sinovac Biotech Gross Profit History

DateAnnualQuarterlyTTM
Dec 2023
$266.75 M(-67.0%)
-
-
Dec 2022
$808.30 M(-95.6%)
-
-
Dec 2021
$18.30 B(+4027.4%)
-
-
Dec 2020
$443.44 M(+107.6%)
$283.93 M(+180.2%)
$443.44 M(+94.2%)
Sept 2020
-
$101.34 M(+126.4%)
$228.38 M(+26.2%)
June 2020
-
$44.77 M(+233.8%)
$181.03 M(-6.8%)
Mar 2020
-
$13.41 M(-80.5%)
$194.22 M(-9.1%)
Dec 2019
$213.58 M(+4.2%)
$68.86 M(+27.5%)
$213.58 M(+11.7%)
Sept 2019
-
$54.00 M(-6.8%)
$191.20 M(+2.5%)
June 2019
-
$57.95 M(+76.8%)
$186.50 M(-3.4%)
Mar 2019
-
$32.77 M(-29.5%)
$193.15 M(-5.7%)
Dec 2018
$204.93 M(+33.0%)
$46.48 M(-5.7%)
$204.93 M(+29.3%)
Sept 2018
-
$49.30 M(-23.7%)
$158.45 M(+45.2%)
June 2018
-
$64.61 M(+45.0%)
$109.15 M(+145.0%)
Mar 2018
-
$44.55 M(+93.4%)
$44.55 M(-11.0%)
Dec 2017
$154.11 M(+208.0%)
-
-
Dec 2016
$50.04 M(+2.1%)
$23.04 M(+0.0%)
$50.04 M(+17.2%)
Sept 2016
-
$23.03 M(-1075.8%)
$42.68 M(+38.3%)
June 2016
-
-$2.36 M(-137.3%)
$30.87 M(-36.3%)
Mar 2016
-
$6.33 M(-59.7%)
$48.44 M(-1.2%)
Dec 2015
$49.01 M(+3.3%)
$15.68 M(+39.8%)
$49.01 M(-0.6%)
Sept 2015
-
$11.21 M(-26.3%)
$49.28 M(-1.9%)
June 2015
-
$15.21 M(+120.4%)
$50.23 M(+13.9%)
Mar 2015
-
$6.90 M(-56.8%)
$44.09 M(-7.1%)
Dec 2014
$47.46 M(-7.4%)
$15.96 M(+31.3%)
$47.46 M(-0.1%)
Sept 2014
-
$12.16 M(+34.1%)
$47.51 M(-4.9%)
June 2014
-
$9.06 M(-11.7%)
$49.95 M(-8.3%)
Mar 2014
-
$10.27 M(-35.9%)
$54.48 M(+6.3%)
Dec 2013
$51.27 M(+70.2%)
$16.02 M(+9.7%)
$51.27 M(+11.1%)
Sept 2013
-
$14.60 M(+7.4%)
$46.14 M(+18.1%)
June 2013
-
$13.59 M(+92.5%)
$39.06 M(+16.7%)
Mar 2013
-
$7.06 M(-35.2%)
$33.46 M(+11.1%)
Dec 2012
$30.12 M
$10.89 M(+44.9%)
$30.12 M(-6.9%)
Sept 2012
-
$7.52 M(-5.9%)
$32.33 M(-3.6%)
DateAnnualQuarterlyTTM
June 2012
-
$7.99 M(+114.9%)
$33.55 M(-7.7%)
Mar 2012
-
$3.72 M(-71.6%)
$36.34 M(+2.0%)
Dec 2011
$35.71 M(+114.1%)
$13.11 M(+50.2%)
$35.62 M(+72.7%)
Sept 2011
-
$8.73 M(-19.0%)
$20.62 M(+12.0%)
June 2011
-
$10.78 M(+259.6%)
$18.41 M(+14.2%)
Mar 2011
-
$3.00 M(-258.8%)
$16.12 M(-3.4%)
Dec 2010
$16.68 M(-74.0%)
-$1.89 M(-128.9%)
$16.68 M(-61.9%)
Sept 2010
-
$6.52 M(-23.2%)
$43.78 M(-20.1%)
June 2010
-
$8.49 M(+138.4%)
$54.81 M(-12.4%)
Mar 2010
-
$3.56 M(-85.9%)
$62.58 M(-2.4%)
Dec 2009
$64.13 M(+75.4%)
$25.21 M(+43.7%)
$64.13 M(+37.4%)
Sept 2009
-
$17.55 M(+8.0%)
$46.67 M(+28.9%)
June 2009
-
$16.26 M(+217.6%)
$36.21 M(+6.9%)
Mar 2009
-
$5.12 M(-33.9%)
$33.86 M(-7.4%)
Dec 2008
$36.56 M(+35.2%)
$7.74 M(+9.2%)
$36.56 M(+4.2%)
Sept 2008
-
$7.09 M(-49.0%)
$35.10 M(-5.6%)
June 2008
-
$13.91 M(+78.0%)
$37.18 M(+27.9%)
Mar 2008
-
$7.81 M(+24.3%)
$29.06 M(+36.8%)
Dec 2007
$27.04 M(+143.1%)
$6.29 M(-31.5%)
$21.25 M(+42.0%)
Sept 2007
-
$9.17 M(+58.4%)
$14.96 M(+158.4%)
June 2007
-
$5.79 M(+209.8%)
$5.79 M(-6.0%)
Dec 2006
$11.12 M(+77.6%)
-
-
June 2006
-
$1.87 M(-12.9%)
$6.16 M(+16.7%)
Dec 2005
$6.26 M(+38.7%)
$2.15 M(0.0%)
$5.28 M(-1.0%)
Sept 2005
-
$2.15 M(+117.8%)
$5.33 M(+34.1%)
June 2005
-
$985.20 K(-55.2%)
$3.97 M(+5.9%)
Dec 2004
$4.52 M(+157.6%)
$2.20 M(+178.4%)
$3.75 M(-563.7%)
Sept 2004
-
$789.30 K(+3.2%)
-$809.00 K(+2.5%)
June 2004
-
$764.80 K(-132.4%)
-$789.30 K(-49.2%)
Dec 2003
$1.75 M(+639.1%)
-$2.36 M(-392.1%)
-$1.55 M(-292.1%)
Sept 2003
-
$809.00 K
$809.00 K
Apr 2002
$237.20 K(+135.6%)
-
-
Apr 2001
$100.70 K(<-9900.0%)
-
-
Apr 2000
-$100.00
-
-

FAQ

  • What is Sinovac Biotech annual gross profit?
  • What is the all time high annual gross profit for Sinovac Biotech?
  • What is the all time high quarterly gross profit for Sinovac Biotech?
  • What is the all time high TTM gross profit for Sinovac Biotech?

What is Sinovac Biotech annual gross profit?

The current annual gross profit of SVA is $266.75 M

What is the all time high annual gross profit for Sinovac Biotech?

Sinovac Biotech all-time high annual gross profit is $18.30 B

What is the all time high quarterly gross profit for Sinovac Biotech?

Sinovac Biotech all-time high quarterly gross profit is $283.93 M

What is the all time high TTM gross profit for Sinovac Biotech?

Sinovac Biotech all-time high TTM gross profit is $443.44 M